FOR AUTHORS
Search
Search Results
Found 32 items.
-
Safety profile of drugs used in the treatment of osteoporosis: a systematical review of the literature
Published: 31 October 20136649PDF: 2419 -
A case of mandible Paget’s disease of the bone treated with intravenous neridronate
Published: 16 December 20161705PDF: 977 -
Regional differences of vitamin D deficiency in rheumatoid arthritis patients in Italy
Published: 23 July 20132935PDF: 1284 -
The negative bone effects of the disease and of chronic corticosteroid treatment in premenopausal women affected by rheumatoid arthritis
Published: 9 September 20161701PDF: 1029 -
Guidelines on prevention and treatment of vitamin D deficiency
Published: 9 November 201110239PDF: 32631 -
The impact on disability of initial treatment with methotrexate in patients with rheumatoid arthritis: results from the MARI study
Published: 31 December 20161588PDF: 886 -
Guidelines for the diagnosis, prevention and management of osteoporosis
Published: 23 June 201617841PDF: 8856 -
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
Published: 31 March 20152338PDF: 2190 -
Vitamin D and rheumatic diseases
Published: 28 July 20143690PDF: 1904 -
Drug-induced osteonecrosis of the jaw: the state of the art
Published: 22 May 20174722PDF: 2759 -
Insight into the WNT system and its drug related response
Published: 18 December 20133053PDF: 1038 -
Duration of treatment for osteoporosis
Published: 28 March 20133390PDF: 1212 -
Effects of secukinumab on serum adipocytokines: preliminary data
Published: 21 September 20172564PDF: 1346 -
Efficacy of mud plus bath therapy as compared to bath therapy in osteoarthritis of hands and knees: a pilot single-blinded randomized controlled trial
Published: 22 November 20215367PDF: 868 -
Incidence and socioeconomic burden of hip fractures in Italy
Published:1309PDF: 3103 -
Vitamin D and disease severity in coronavirus disease 19 (COVID-19)
Published: 18 January 20212431PDF: 1318 -
Use of nonsteroidal anti-inflammatory drugs in patients with vertebral osteoporotic fractures
Published:959PDF: 698 -
Risk factors for hip fracture in elderly persons
Published:2316PDF: 3989 -
Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-life
Published: 23 July 20201343PDF: 933 -
Diffuse idiopathic skeletal hyperostosis is associated with greater complexity of coronary artery disease burden on coronary angiography
Published: 1 October 2024560PDF: 69 -
Guidelines for the diagnosis, prevention and treatment of osteoporosis
Published:3107PDF: 3897 -
Radiological features of knee joint synovial chondromatosis
Published: 9 July 20191267PDF: 843 -
Gender differences in clinical features and quality of life of patients with axial spondyloarthritis and psoriatic arthritis
Published: 11 September 2024904PDF: 162 -
Vitamin D and fractures: a sistematic review
Published:1320PDF: 1524 -
Vitamin D: no efficacy without deficiency. What’s new?
Published: 9 July 20191513PDF: 1075 -
Expert opinion on the management of patients with osteoporosis with anabolic drugs in Italy
Published: 24 June 20242760PDF: 1101 -
Inflammatory markers predict insulin sensitivity in active rheumatoid arthritis but not in psoriatic arthritis
Published: 20 December 20181199PDF: 804 -
Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement
Published: 8 May 20231143PDF: 654
1 - 32 of 32 items